Selected research
Market Structure
Global Injectable Cement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Injectable Cement market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Injectable Cement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Injectable Cement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Injectable Cement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Injectable Cement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Injectable Cement include Stryker, Johnson & Johnson, Medtronic, TSMRI, TEKNIMED, Tecres, Somatex Medical Technologies, Smith & Nephew and Osseon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Injectable Cement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Injectable Cement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Injectable Cement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Cement market size, projected growth trends, production technologies, key applications, and end-use industries.
Injectable Cement Segment by Company
Stryker
Johnson & Johnson
Medtronic
TSMRI
TEKNIMED
Tecres
Somatex Medical Technologies
Smith & Nephew
Osseon
Medacta International
Heraeus Medical
G-21
DJO Global
Cook Medical
B. Braun Melsungen AG
Alphatec Spine
Injectable Cement Segment by Type
Low Viscosity Cements
High Viscosity Vements
Medium Viscosity Cements
Injectable Cement Segment by Application
Periprosthetic Fractures
Pelvic Fractures
Others
Injectable Cement Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Cement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Cement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Cement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Injectable Cement market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Cement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Cement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Injectable Cement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Low Viscosity Cements
- High Viscosity Vements
- Medium Viscosity Cements
Applications
- Periprosthetic Fractures
- Pelvic Fractures
- Others
Companies covered
- Stryker
- Johnson & Johnson
- Medtronic
- TSMRI
- TEKNIMED
- Tecres
- Somatex Medical Technologies
- Smith & Nephew
- Osseon
- Medacta International
- Heraeus Medical
- G-21
- DJO Global
- Cook Medical
- B. Braun Melsungen AG
- Alphatec Spine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Injectable Cement Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Injectable Cement Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Injectable Cement Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Injectable Cement Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Injectable Cement Market Dynamics
- 2.1 Injectable Cement Industry Trends
- 2.2 Injectable Cement Industry Drivers
- 2.3 Injectable Cement Industry Opportunities and Challenges
- 2.4 Injectable Cement Industry Restraints
3 Injectable Cement Market by Manufacturers
- 3.1 Global Injectable Cement Revenue by Manufacturers (2021-2026)
- 3.2 Global Injectable Cement Sales by Manufacturers (2021-2026)
- 3.3 Global Injectable Cement Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Injectable Cement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Injectable Cement Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Injectable Cement Manufacturers, Product Type & Application
- 3.7 Global Injectable Cement Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Injectable Cement Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Injectable Cement Players Market Share by Revenue in 2025
- 3.8.3 2025 Injectable Cement Tier 1, Tier 2, and Tier 3
4 Injectable Cement Market by Type
- 4.1 Injectable Cement Type Introduction
- 4.1.1 Low Viscosity Cements
- 4.1.2 High Viscosity Vements
- 4.1.3 Medium Viscosity Cements
- 4.2 Global Injectable Cement Sales by Type
- 4.2.1 Global Injectable Cement Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Injectable Cement Sales by Type (2021-2032)
- 4.2.3 Global Injectable Cement Sales Market Share by Type (2021-2032)
- 4.3 Global Injectable Cement Revenue by Type
- 4.3.1 Global Injectable Cement Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Injectable Cement Revenue by Type (2021-2032)
- 4.3.3 Global Injectable Cement Revenue Market Share by Type (2021-2032)
5 Injectable Cement Market by Application
- 5.1 Injectable Cement Application Introduction
- 5.1.1 Periprosthetic Fractures
- 5.1.2 Pelvic Fractures
- 5.1.3 Others
- 5.2 Global Injectable Cement Sales by Application
- 5.2.1 Global Injectable Cement Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Injectable Cement Sales by Application (2021-2032)
- 5.2.3 Global Injectable Cement Sales Market Share by Application (2021-2032)
- 5.3 Global Injectable Cement Revenue by Application
- 5.3.1 Global Injectable Cement Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Injectable Cement Revenue by Application (2021-2032)
- 5.3.3 Global Injectable Cement Revenue Market Share by Application (2021-2032)
6 Global Injectable Cement Sales by Region
- 6.1 Global Injectable Cement Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Injectable Cement Sales by Region (2021-2032)
- 6.2.1 Global Injectable Cement Sales by Region (2021-2026)
- 6.2.2 Global Injectable Cement Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Injectable Cement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Injectable Cement Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Injectable Cement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Injectable Cement Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Injectable Cement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Injectable Cement Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Injectable Cement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Injectable Cement Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Injectable Cement Revenue by Region
- 7.1 Global Injectable Cement Revenue by Region
- 7.1.1 Global Injectable Cement Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Injectable Cement Revenue by Region (2021-2026)
- 7.1.3 Global Injectable Cement Revenue by Region (2027-2032)
- 7.1.4 Global Injectable Cement Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Injectable Cement Revenue (2021-2032)
- 7.2.2 North America Injectable Cement Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Injectable Cement Revenue (2021-2032)
- 7.3.2 Europe Injectable Cement Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Injectable Cement Revenue (2021-2032)
- 7.4.2 Asia-Pacific Injectable Cement Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Injectable Cement Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Injectable Cement Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Stryker
- 8.1.1 Stryker Company Information
- 8.1.2 Stryker Business Overview
- 8.1.3 Stryker Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Stryker Injectable Cement Product Portfolio
- 8.1.5 Stryker Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Injectable Cement Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Medtronic
- 8.3.1 Medtronic Company Information
- 8.3.2 Medtronic Business Overview
- 8.3.3 Medtronic Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Medtronic Injectable Cement Product Portfolio
- 8.3.5 Medtronic Recent Developments
- 8.4 TSMRI
- 8.4.1 TSMRI Company Information
- 8.4.2 TSMRI Business Overview
- 8.4.3 TSMRI Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 TSMRI Injectable Cement Product Portfolio
- 8.4.5 TSMRI Recent Developments
- 8.5 TEKNIMED
- 8.5.1 TEKNIMED Company Information
- 8.5.2 TEKNIMED Business Overview
- 8.5.3 TEKNIMED Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 TEKNIMED Injectable Cement Product Portfolio
- 8.5.5 TEKNIMED Recent Developments
- 8.6 Tecres
- 8.6.1 Tecres Company Information
- 8.6.2 Tecres Business Overview
- 8.6.3 Tecres Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Tecres Injectable Cement Product Portfolio
- 8.6.5 Tecres Recent Developments
- 8.7 Somatex Medical Technologies
- 8.7.1 Somatex Medical Technologies Company Information
- 8.7.2 Somatex Medical Technologies Business Overview
- 8.7.3 Somatex Medical Technologies Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Somatex Medical Technologies Injectable Cement Product Portfolio
- 8.7.5 Somatex Medical Technologies Recent Developments
- 8.8 Smith & Nephew
- 8.8.1 Smith & Nephew Company Information
- 8.8.2 Smith & Nephew Business Overview
- 8.8.3 Smith & Nephew Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Smith & Nephew Injectable Cement Product Portfolio
- 8.8.5 Smith & Nephew Recent Developments
- 8.9 Osseon
- 8.9.1 Osseon Company Information
- 8.9.2 Osseon Business Overview
- 8.9.3 Osseon Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Osseon Injectable Cement Product Portfolio
- 8.9.5 Osseon Recent Developments
- 8.10 Medacta International
- 8.10.1 Medacta International Company Information
- 8.10.2 Medacta International Business Overview
- 8.10.3 Medacta International Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Medacta International Injectable Cement Product Portfolio
- 8.10.5 Medacta International Recent Developments
- 8.11 Heraeus Medical
- 8.11.1 Heraeus Medical Company Information
- 8.11.2 Heraeus Medical Business Overview
- 8.11.3 Heraeus Medical Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Heraeus Medical Injectable Cement Product Portfolio
- 8.11.5 Heraeus Medical Recent Developments
- 8.12 G-21
- 8.12.1 G-21 Company Information
- 8.12.2 G-21 Business Overview
- 8.12.3 G-21 Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 G-21 Injectable Cement Product Portfolio
- 8.12.5 G-21 Recent Developments
- 8.13 DJO Global
- 8.13.1 DJO Global Company Information
- 8.13.2 DJO Global Business Overview
- 8.13.3 DJO Global Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 DJO Global Injectable Cement Product Portfolio
- 8.13.5 DJO Global Recent Developments
- 8.14 Cook Medical
- 8.14.1 Cook Medical Company Information
- 8.14.2 Cook Medical Business Overview
- 8.14.3 Cook Medical Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Cook Medical Injectable Cement Product Portfolio
- 8.14.5 Cook Medical Recent Developments
- 8.15 B. Braun Melsungen AG
- 8.15.1 B. Braun Melsungen AG Company Information
- 8.15.2 B. Braun Melsungen AG Business Overview
- 8.15.3 B. Braun Melsungen AG Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 B. Braun Melsungen AG Injectable Cement Product Portfolio
- 8.15.5 B. Braun Melsungen AG Recent Developments
- 8.16 Alphatec Spine
- 8.16.1 Alphatec Spine Company Information
- 8.16.2 Alphatec Spine Business Overview
- 8.16.3 Alphatec Spine Injectable Cement Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Alphatec Spine Injectable Cement Product Portfolio
- 8.16.5 Alphatec Spine Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Injectable Cement Value Chain Analysis
- 9.1.1 Injectable Cement Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Injectable Cement Production Mode & Process
- 9.2 Injectable Cement Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Injectable Cement Distributors
- 9.2.3 Injectable Cement Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst